<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03458533</url>
  </required_header>
  <id_info>
    <org_study_id>4249</org_study_id>
    <nct_id>NCT03458533</nct_id>
  </id_info>
  <brief_title>Changes in the Hypotalamic-pituitary Region of Patients With Metabolic Syndrome and Obesity</brief_title>
  <acronym>CHIASM</acronym>
  <official_title>Changes in the Hypotalamic-pituitary Region of Patients With Metabolic Syndrome and Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to identify new morphological and quantitative magnetic imaging parameters of
      pituitary gland and sellar region in overweight and obese patient at baseline and after 3
      years, dividing patients in 3 groups (weight loss through diet and lifestyle changes, weight
      loss through bariatric surgery, no weight loss)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This longitudinal prospective study in overweight and obese patients aims to identify and
      characterize new morphological and quantitative MRI parameters of pituitary gland and sellar
      region assessed by texture analysis with a specific software (ImageJÂ©). These parameters will
      be correlated them to hypothalamic-pituitary-peripheral axis function, metabolism and body
      composition.

      Data will be detected at baseline and at 3 years follow-up to quantitatively identify the
      different pituitary MRI patterns in 3 groups:

        1. patients without weight modifies

        2. patients with weight loss obtain through diet and lifestyle changes

        3. patients with weight loss obtained through bariatric surgery
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pituitary volume</measure>
    <time_frame>0, +3 years</time_frame>
    <description>Change in pituitary volume (mm3) from baseline to 3 years</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of pituitary mean and standard deviation intensity</measure>
    <time_frame>0, +3 years</time_frame>
    <description>Changes in new quantitative magnetic imaging parameters of pituitary gland from baseline to 3 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of magnetic resonance parameters with anthropometric measurements</measure>
    <time_frame>0, +3 years</time_frame>
    <description>Correlation analysis of pituitary mean and standard deviation intensity with anthropometric measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of magnetic resonance parameters with pituitary axis function</measure>
    <time_frame>0, +3 years</time_frame>
    <description>Correlation analysis of pituitary mean and standard deviation intensity with pituitary axis function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of magnetic resonance parameters with glyco-metabolic status</measure>
    <time_frame>0, +3 years</time_frame>
    <description>Correlation analysis of pituitary mean and standard deviation intensity with glyco-metabolic status</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Overweight and Obesity</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Obese patients with indication to bariatric surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Overweight or obese patients without indication to bariatric surgery, able to obtain weight loss trough diet and lifestyle changes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>Overweight or obese patients without indication to bariatric surgery, not able to obtain weight loss trough diet and lifestyle changes</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bariatric surgery</intervention_name>
    <arm_group_label>Group 1</arm_group_label>
    <other_name>sleeve gastrectomy</other_name>
    <other_name>gastric bypass</other_name>
    <other_name>bilio-intestinal bypass</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diet and lifestyle changes</intervention_name>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
    <other_name>hypocaloric diet</other_name>
    <other_name>physical exercise</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Overweight and obese patients come to our attention for weight loss interventions
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 25 Kg/m2

        Exclusion Criteria:

          -  Malignant neoplasia;

          -  Current use of psychotropic drugs;

          -  Chronic renal failure;

          -  Pituitary macroadenomas and craniopharyngiomas;

          -  Contraindications to MRI execution (p. e. pace-maker, metal foreign bodies like
             slivers, non MRI compatible vascular clips or prosthesis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea M Isidori, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sapienza, University of Rome</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea M Isidori, MD, PhD</last_name>
    <phone>00390649970540</phone>
    <email>andrea.isidori@uniroma1.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Andrea M Isidori</name>
      <address>
        <city>Rome</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea M Isidori, MD, PhD</last_name>
      <phone>00390649970540</phone>
      <email>andrea.isidori@uniroma1.it</email>
    </contact>
    <investigator>
      <last_name>Andrea M Isidori, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giulia Puliani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2018</study_first_submitted>
  <study_first_submitted_qc>March 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Andrea M. Isidori</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Pituitary</keyword>
  <keyword>Obesity</keyword>
  <keyword>Overweight</keyword>
  <keyword>Metabolic syndrome</keyword>
  <keyword>MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Pituitary Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

